Mitchell H. Finer

Mitchell H Finer Ph.D. has extensive experience in the biotechnology and pharmaceutical sectors, currently serving as a Strategic Advisor at ElevateBio since January 2018, while also holding multiple leadership roles, including President of Research and Development and President of ElevateBio Base Camp. As a co-founder and Chief Scientific Officer at Abata Therapeutics since June 2021, Mitchell has been instrumental in advancing innovative therapies. Other notable roles include Chief Executive Officer at LifeEDIT, Founder and Executive Chairman at Oncorus, and Chief Scientific Officer at bluebirdbio. With a strong academic background, including a Ph.D. in Biochemistry and Molecular Biology from Harvard University, Mitchell specializes in gene editing technologies, oncology therapeutics, and product development for genetic disorders.